CryoPort, Inc.

  • Market Cap: Micro Cap
  • Industry: Transport Services
  • ISIN: US2290503075
USD
9.88
0.67 (7.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

488.47 k

Shareholding (Mar 2025)

FII

22.85%

Held by 93 FIIs

DII

34.21%

Held by 49 DIIs

Promoter

1.06%

How big is CryoPort, Inc.?

22-Jun-2025

As of Jun 18, CryoPort, Inc. has a market capitalization of 337.92 million and reported net sales of 214.83 million with a net profit of -104.89 million over the last four quarters. Shareholder's funds are 401.90 million, and total assets amount to 703.49 million.

As of Jun 18, CryoPort, Inc. has a market capitalization of 337.92 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 214.83 million, while the sum of net profit for the same period is -104.89 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at 401.90 million, and total assets amount to 703.49 million.

Read More

What does CryoPort, Inc. do?

22-Jun-2025

CryoPort, Inc. is a life sciences services company focused on supply chain solutions for biopharma, reproductive medicine, and animal health markets. As of March 2025, it reported net sales of $41 million and a net loss of $9 million, with a market cap of $337.92 million.

Overview: <BR>CryoPort, Inc. is a life sciences services company in the Transport Services industry, specializing in the supply chain for biopharma, reproductive medicine, and animal health markets.<BR><BR>Financial Snapshot: <BR>Net Sales: 41 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -9 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 337.92 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.10 <BR>Return on Equity: -14.06% <BR>Price to Book: 0.85<BR><BR>Contact Details: <BR>Address: 112 Westwood Pl Ste 350, BRENTWOOD TN: 37027-5332 <BR>Tel: ['1 949 2321900', '1 212 6826300'] <BR>Fax: 1 949 4702306 <BR>Website: https://www.cryoport.com/

Read More

Should I buy, sell or hold CryoPort, Inc.?

22-Jun-2025

Who are in the management team of CryoPort, Inc.?

22-Jun-2025

As of March 2022, the management team of CryoPort, Inc. includes Jerrell Shelton (Chairman, President, CEO), Richard Berman (Lead Independent Director), Daniel Hancock, Ram Jagannath, Robert Hariri, and Ramkumar Mandalam (all Directors).

As of March 2022, the management team of CryoPort, Inc. includes the following individuals:<BR><BR>- Mr. Jerrell Shelton: Chairman of the Board, President, and Chief Executive Officer<BR>- Mr. Richard Berman: Lead Independent Director<BR>- Mr. Daniel Hancock: Director<BR>- Mr. Ram Jagannath: Director<BR>- Dr. Robert Hariri: Independent Director<BR>- Dr. Ramkumar Mandalam: Independent Director

Read More

Is CryoPort, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, CryoPort, Inc. shows a mildly bullish trend with positive indicators like MACD and Bollinger Bands, but caution is advised due to recent trend changes and long-term underperformance compared to the S&P 500.

As of 12 September 2025, the technical trend for CryoPort, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum but with some weakening. Bollinger Bands are bullish on both weekly and monthly time frames, supporting the upward price action. Daily moving averages are also bullish, reinforcing the current positive trend. The KST is bullish weekly and mildly bullish monthly, while Dow Theory shows a mildly bullish stance on a monthly basis. <BR><BR>In terms of performance, CryoPort has outperformed the S&P 500 across multiple periods, with a 1-week return of 6.12% compared to 1.05% for the S&P 500, and a 1-month return of 14.33% versus 2.33%. However, longer-term returns over 3 and 5 years show significant underperformance relative to the benchmark. Overall, the current stance is mildly bullish, driven by positive indicators, but with caution advised due to the trend change.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • OPERATING CASH FLOW(Y) Lowest at USD -16.71 MM
  • NET SALES(Q) At USD 45.45 MM has Fallen at -15.37%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 5.35 times
2

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Transport Services

stock-summary
Market cap

USD 503 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.46

stock-summary
Return on Equity

-10.37%

stock-summary
Price to Book

0.98

Revenue and Profits:
Net Sales:
45 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.24%
0%
16.24%
6 Months
69.18%
0%
69.18%
1 Year
32.8%
0%
32.8%
2 Years
-33.33%
0%
-33.33%
3 Years
-50.58%
0%
-50.58%
4 Years
-84.4%
0%
-84.4%
5 Years
-79.13%
0%
-79.13%

CryoPort, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
39.78%
EBIT Growth (5y)
-183.52%
EBIT to Interest (avg)
-9.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.30
Tax Ratio
1.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.88
EV to EBIT
-5.19
EV to EBITDA
-10.74
EV to Capital Employed
0.87
EV to Sales
1.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.69%
ROE (Latest)
-14.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (41.84%)

Foreign Institutions

Held by 93 Foreign Institutions (22.85%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10.98% vs -31.09% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -33.33% vs 51.87% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.50",
          "val2": "41.00",
          "chgp": "10.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-7.00",
          "chgp": "67.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "5.80",
          "chgp": "-101.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.00",
          "val2": "-9.00",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-211.60%",
          "val2": "-357.20%",
          "chgp": "14.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.10% vs -1.69% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -15.26% vs -167.02% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "228.40",
          "val2": "233.30",
          "chgp": "-2.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-37.20",
          "val2": "-31.20",
          "chgp": "-19.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "5.50",
          "chgp": "-25.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-45.30",
          "val2": "-49.50",
          "chgp": "8.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-114.80",
          "val2": "-99.60",
          "chgp": "-15.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-297.80%",
          "val2": "-251.40%",
          "chgp": "-4.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
45.50
41.00
10.98%
Operating Profit (PBDIT) excl Other Income
-2.30
-7.00
67.14%
Interest
0.60
0.60
Exceptional Items
-0.10
5.80
-101.72%
Consolidate Net Profit
-12.00
-9.00
-33.33%
Operating Profit Margin (Excl OI)
-211.60%
-357.20%
14.56%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 10.98% vs -31.09% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -33.33% vs 51.87% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
228.40
233.30
-2.10%
Operating Profit (PBDIT) excl Other Income
-37.20
-31.20
-19.23%
Interest
4.10
5.50
-25.45%
Exceptional Items
-45.30
-49.50
8.48%
Consolidate Net Profit
-114.80
-99.60
-15.26%
Operating Profit Margin (Excl OI)
-297.80%
-251.40%
-4.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.10% vs -1.69% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -15.26% vs -167.02% in Dec 2023

stock-summaryCompany CV
About CryoPort, Inc. stock-summary
stock-summary
CryoPort, Inc.
Transport Services
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.
Company Coordinates stock-summary
Company Details
112 Westwood Pl Ste 350 , BRENTWOOD TN : 37027-5332
stock-summary
Tel: 1 949 23219001 212 6826300
stock-summary
Registrar Details